Influence of Trough Serum Levels and Immunogenicity onLong-term Outcome of Adalimumab Therapy in Crohn's Disease(Gastroenterology 2009;137:1628-1640).
- Author:
Geom Seog SEO
1
Author Information
1. Digestive Disease Research Institute, Department of Internal Medicine,College of Medicine, Wonkwang University, Iksan, Korea. medsgs@wonkwang.ac.kr
- Publication Type:Selected Summary
- MeSH:
Adalimumab;
Antibodies, Monoclonal, Humanized
- From:Intestinal Research
2009;7(2):135-136
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
No abstract available.
